FDA Investigator Thao X Tran
Thao X Tran has conducted inspections on 11 sites in 4 countries as of 08 Jan 2007. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
08 Jan 2007
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Denmark,
Belgium,
Germany
FDA Investigators that have inspected at least one site in common with Thao X Tran:
Alexandra B Pitkin,
Alexandria L Capuano,
Amalia C Himaya,
Amanda L Fyles,
Amir Alavi,
Anastasia M Shields,
Andrea A Branche,
Anita Narula, PhD,
Ashley A Mutawakkil,
Barry Cherney, PhD,
Bichsa T Tran,
Binh T Nguyen,
Bo Chi, PhD,
Bonnie I Needleman,
Brian J Ryan,
Brien C Fox,
Bryan A Galvez,
Carla J Lundi,
Carolyn E Barney,
Carrie A Hughes,
Caryn M Mcnab,
Cathleen A Carr Sharpe,
Cecilia H Kieu,
Celena Ngo,
Chelsea N Sealey,
Cheron M Portee,
Christina C Santos,
Christina V Santos,
Christopher R Czajka,
Connie L Hannon Rabel,
Daniel W Cline,
Davinna Ligons, PhD,
Diana M Rand,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Dogbeda F Mackenzie,
Donna Ltartaglino Besone,
Donna Mwilliams Hill, PhD,
Dr. Chunchang Fang,
Elaine A Bunch,
Esther C Broner, PhD,
Evelyn Wong,
Frances Namuswe, PhD,
Gabriel Craig,
Gene D Arcy,
Greg K Keshishyan,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Iris C Macinnes,
J Elkins,
James A Barreto,
James R Fleckenstein,
James W Leonette,
Jazmine M Welcher,
Jd Young,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Jocelyn E Massey,
Jocelyn E Sparks,
Joel Welch, PhD,
Joey V Quitania,
John A Gonzalez,
John R Myung,
Judy C Nepsa,
Junho Pak,
Ka L Wong,
Kathleen R Jones, PhD,
Kelley,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kevin T Gerrity,
Kham Phommachanh,
Kim Lthomas Cruse,
Kirtida Patel,
Lacresha Menifee,
Laura Fontan, MS,
Lauren E Skokan,
Laurenee L Adeoshun,
Leonard H Lavi,
Liming Zhang,
Linda F Murphy,
Linda Thai,
Lucas B Leake,
Luis P Torres,
Marcia B Williams,
Marcus F Yambot,
Maxyne T Lam,
Michael D Garcia,
Michael J Nerz,
Michelle A Marsh,
Mihaly S Ligmond,
Minh D Phan,
Mohsen Rajabi Abhari, FDA,
Nabeela J Chaudhry,
Nancy L Neiger,
Naveen B Walker,
Nelly N Tran,
Nianna C Burns,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Omotunde O Osunsanmi,
Paul E Stein,
Pauline N Logan,
Peter S Diak,
Phillip L Toy,
Quyen T Tien,
Raymond W Brullo,
Rebecca Rodriguez,
Richard L Rutherford,
Richard W Tubb,
Richmond K Yip,
Robert C Hoover,
Robert D Tollefsen,
Robert Darius,
Rocio Guzman Velazquez,
Roger F Zabinski,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Sabrina J Dethloff,
Sandra L Shire, DMD, MPA,
Sarah Arden,
Scott R Nichols, PhD,
Sean P Desbrow,
Shaquenta Y Perkins,
Sidney B Priesmeyer,
Sidonie J Takougang,
Sonia R Peterson,
Stanley Au,
Steven E Porter, Jr,
Steven Fong, MS, PhD,
Sundy V Sedwick,
Taichun Qin, PhD,
Tamika White,
Teresa I Navas,
Terri L Dodds,
Thai T Duong,
Thao T Kwan,
Thomas Thierry,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Trushani T Desai,
Uttaniti Limchumroon (Tom),
Vien Q Le,
Virgilio F Pacio, CSO,
Walden H Lee,
Wenzheng Wendy Zhang,
Yumi J Hiramine,
Yvette Mlacour Davis,
Yvonne C Wilkes
Thao X Tran's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| July, 2002 | FDA 483 | Amgen, Inc - Form 483, 2002-07-25 |
| August, 2005 | EIR | Saputo Cheese USA Inc - EIR, 2005-08-26 |
| July, 2002 | EIR | Amgen, Inc - EIR, 2002-07-25 |
| August, 2003 | FDA 483 | General Research Laboratories - Form 483, 2003-08-01 |
| September, 2006 | FDA 483 | R.P. Kincheloe dba Perkins Healthcare Technologies - Form 483, 2006-09-25 |
| April, 2000 | FDA 483 | Dimequip - Form 483, 2000-04-28 |
| July, 2003 | FDA 483 | President Global Corp. - Form 483, 2003-07-14 |
| August, 2003 | EIR | General Research Laboratories - EIR, 2003-08-15 |
| January, 2007 | EIR | Bioduro LLC - EIR, 2007-01-22 |
| January, 2006 | EIR | B. Braun Medical Inc. - EIR, 2006-01-25 |
| July, 2002 | FDA 483 Response | Amgen, Inc - Form 483R, 2002-08-09 |
| May, 2000 | FDA 483 | Carl Zeiss Jena Gmbh - Form 483, 2000-05-05 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more